NDRA   $4.44  5.97% Market Closed

ENDRA Life Sciences Inc.
Total Cash 6.40M
totalCashPerShare 4.418
EBITDA -9.52M
Total Debt 549.13K
quickRatio 4.741
currentRatio 4.972
Total Revenue
debtToEquity 6.106
Revenue/Share
ROA -0.60942
ROE -1.20132
grossProfits
freeCashflow -2.48M
operatingCashflow -9.00M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -5.48M
forwardPE -0.024601571
floatShares 1.45M
sharesOutstanding 18.14M
sharesShort 717.67K
sharesShortPriorMonth 63.15K
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.00%
Short Ratio help_outline 0.51%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue 6.208
Price To Book help_outline 0.04
earningsQuarterlyGrowth
netIncomeToCommon -9.57M
trailingEps -32.00%
forwardEps -8.91%
enterpriseToEbitda 0.57
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.78 3Q 2024
institutionsCount 15
lastUpdated Nov. 7, 2024, 2:35 a.m.